{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:30:25Z","timestamp":1761265825231,"version":"build-2065373602"},"reference-count":33,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100015204","name":"International Hepato-Pancreato-Biliary Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015204","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","hpbonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["HPB"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.hpb.2019.04.002","type":"journal-article","created":{"date-parts":[[2019,5,20]],"date-time":"2019-05-20T09:12:07Z","timestamp":1558343527000},"page":"1648-1655","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Patterns of gene mutations in bile duct cancers: is it time to overcome the anatomical classification?"],"prefix":"10.1016","volume":"21","author":[{"given":"Fabio","family":"Bagante","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Ruzzenente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simone","family":"Conci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Borislav C.","family":"Rusev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Simbolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tommaso","family":"Campagnaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy M.","family":"Pawlik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudio","family":"Luchini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Calogero","family":"Iacono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aldo","family":"Scarpa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfredo","family":"Guglielmi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.hpb.2019.04.002_bib1","first-page":"7","article-title":"Cancer statistics, 2017","volume":"67","author":"Siegel","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.hpb.2019.04.002_bib2","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1159\/000449493","article-title":"Current status on cholangiocarcinoma and gallbladder cancer","volume":"6","author":"Ebata","year":"2016","journal-title":"Liver Cancer"},{"key":"10.1016\/j.hpb.2019.04.002_bib3","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1007\/s11605-017-3550-7","article-title":"Defining long-term survivors following resection of intrahepatic cholangiocarcinoma","volume":"21","author":"Bagante","year":"2017","journal-title":"J\u00a0Gastrointest Surg"},{"key":"10.1016\/j.hpb.2019.04.002_bib4","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1007\/s00268-016-3691-y","article-title":"Defining the chance of statistical cure among patients with extrahepatic biliary tract cancer","volume":"41","author":"Spolverato","year":"2017","journal-title":"World J Surg"},{"key":"10.1016\/j.hpb.2019.04.002_bib5","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1002\/jso.24759","article-title":"Performance of prognostic scores and staging systems in predicting long-term survival outcomes after surgery for intrahepatic cholangiocarcinoma","volume":"116","author":"Buettner","year":"2017","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.hpb.2019.04.002_bib6","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1007\/s11605-012-1935-1","article-title":"Neither neoadjuvant nor adjuvant therapy increases survival after biliary tract cancer resection with wide negative margins","volume":"16","author":"Glazer","year":"2012","journal-title":"J\u00a0Gastrointest Surg"},{"key":"10.1016\/j.hpb.2019.04.002_bib7","series-title":"AJCC cancer staging manual","first-page":"648","author":"Edge","year":"2010"},{"issue":"4","key":"10.1016\/j.hpb.2019.04.002_bib8","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1245\/s10434-017-6025-x","article-title":"8th edition of the AJCC cancer staging manual: pancreas and hepatobiliary cancers","volume":"25","author":"Chun","year":"2017","journal-title":"Ann Surg Oncol"},{"issue":"suppl","key":"10.1016\/j.hpb.2019.04.002_bib9","article-title":"Gemox versus surveillance following surgery of localized biliary tract cancer: results of the PRODIGE 12-ACCORD 18 (UNICANCER GI) phase III trial","volume":"35","author":"Edeline","year":"2017","journal-title":"J\u00a0Clin Oncol"},{"issue":"suppl","key":"10.1016\/j.hpb.2019.04.002_bib10","article-title":"Adjuvant capecitabine for biliary tract cancer: the BILCAP randomized study","volume":"35","author":"Primrose","year":"2017","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.hpb.2019.04.002_bib11","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJMoa0908721","article-title":"Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer","volume":"362","author":"Valle","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hpb.2019.04.002_bib12","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1016\/j.celrep.2017.02.033","article-title":"Integrative genomic analysis of cholangiocarcinoma identifies distinct IDH-mutant molecular profiles","volume":"18","author":"Farshidfar","year":"2017","journal-title":"Cell Rep"},{"year":"2017","series-title":"Whole-genome and epigenomic landscapes of etiologically distinct subtypes of cholangiocarcinoma","author":"Jusakul","key":"10.1016\/j.hpb.2019.04.002_bib13"},{"key":"10.1016\/j.hpb.2019.04.002_bib14","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1586\/14737159.2016.1146593","article-title":"Toward clinical genomics in everyday medicine: perspectives and recommendations","volume":"16","author":"Delaney","year":"2016","journal-title":"Expert Rev Mol Diagn"},{"key":"10.1016\/j.hpb.2019.04.002_bib15","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.18632\/oncotarget.1943","article-title":"Multigene mutational profiling of cholangiocarcinomas identifies actionable molecular subgroups","volume":"5","author":"Simbolo","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.hpb.2019.04.002_bib16","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jclinepi.2015.04.005","article-title":"Prediction models need appropriate internal, internal-external, and external validation","volume":"69","author":"Steyerberg","year":"2016","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.hpb.2019.04.002_bib17","doi-asserted-by":"crossref","first-page":"5668","DOI":"10.3748\/wjg.v22.i25.5668","article-title":"Genomic diversity of colorectal cancer: changing landscape and emerging targets","volume":"22","author":"Ahn","year":"2016","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.hpb.2019.04.002_bib18","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nature17676","article-title":"Landscape of somatic mutations in 560 breast cancer whole-genome sequences","volume":"534","author":"Nik-Zainal","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.hpb.2019.04.002_bib19","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1245\/s10434-015-5046-6","article-title":"Cholangiocarcinoma heterogeneity revealed by multigene mutational profiling: clinical and prognostic relevance in surgically resected patients","volume":"23","author":"Ruzzenente","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.hpb.2019.04.002_bib20","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1002\/jso.24569","article-title":"Comparative performances of the 7th and the 8th editions of the American Joint Committee on Cancer staging systems for intrahepatic cholangiocarcinoma","volume":"115","author":"Spolverato","year":"2017","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.hpb.2019.04.002_bib21","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1200\/JCO.2012.41.5984","article-title":"Prognostic nomogram for intrahepatic cholangiocarcinoma after partial hepatectomy","volume":"31","author":"Wang","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.hpb.2019.04.002_bib22","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1001\/jamasurg.2013.5168","article-title":"A\u00a0nomogram to predict long-term survival after resection for intrahepatic cholangiocarcinoma: an Eastern and Western experience","volume":"149","author":"Hyder","year":"2014","journal-title":"JAMA Surg"},{"key":"10.1016\/j.hpb.2019.04.002_bib23","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/cncr.29686","article-title":"Proposal of a new staging system for intrahepatic cholangiocarcinoma: analysis of surgical patients from a nationwide survey of the Liver Cancer Study Group of Japan","volume":"122","author":"Sakamoto","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.hpb.2019.04.002_bib24","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/jhbp.92","article-title":"Proposal of a new staging system for mass-forming intrahepatic cholangiocarcinoma: a multicenter analysis by the Study Group for Hepatic Surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery","volume":"21","author":"Uenishi","year":"2014","journal-title":"J\u00a0Hepatobiliary Pancreat Sci"},{"key":"10.1016\/j.hpb.2019.04.002_bib25","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1002\/1097-0142(20011101)92:9<2374::AID-CNCR1585>3.0.CO;2-L","article-title":"A\u00a0new staging system for mass-forming intrahepatic cholangiocarcinoma: analysis of preoperative and postoperative variables","volume":"92","author":"Okabayashi","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.hpb.2019.04.002_bib26","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1245\/s10434-008-0180-z","article-title":"A\u00a0proposed staging system for intrahepatic cholangiocarcinoma","volume":"16","author":"Nathan","year":"2009","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.hpb.2019.04.002_bib27","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1007\/s11605-016-3203-2","article-title":"A\u00a0comparison of prognostic schemes for perihilar cholangiocarcinoma","volume":"20","author":"Buettner","year":"2016","journal-title":"J\u00a0Gastrointest Surg"},{"key":"10.1016\/j.hpb.2019.04.002_bib28","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1093\/annonc\/mdw063","article-title":"Survival after resection of perihilar cholangiocarcinoma-development and external validation of a prognostic nomogram","volume":"27","author":"Groot Koerkamp","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1016\/j.hpb.2019.04.002_bib29","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1038\/ng.2813","article-title":"Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas","volume":"45","author":"Jiao","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.hpb.2019.04.002_bib30","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1200\/JCO.2014.59.8433","article-title":"Basket trials and the evolution of clinical trial design in an era of genomic medicine","volume":"33","author":"Redig","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.hpb.2019.04.002_bib31","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1200\/JCO.2016.69.9751","article-title":"Basket trials in oncology: a trade-off between complexity and efficiency","volume":"35","author":"Cunanan","year":"2017","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.hpb.2019.04.002_bib32","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1001\/jamaoncol.2016.2214","article-title":"Genomics- and transcriptomics-based patient selection for cancer treatment with immune checkpoint inhibitors: a review","volume":"2","author":"Dijkstra","year":"2016","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.hpb.2019.04.002_bib33","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-014961","article-title":"Study protocol of a phase IB\/II clinical trial of metformin and chloroquine in patients with IDH1-mutated or IDH2-mutated solid tumours","volume":"7","author":"Molenaar","year":"2017","journal-title":"BMJ Open"}],"container-title":["HPB"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1365182X19305131?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1365182X19305131?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:21:27Z","timestamp":1761265287000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1365182X19305131"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":33,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["S1365182X19305131"],"URL":"https:\/\/doi.org\/10.1016\/j.hpb.2019.04.002","relation":{},"ISSN":["1365-182X"],"issn-type":[{"type":"print","value":"1365-182X"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patterns of gene mutations in bile duct cancers: is it time to overcome the anatomical classification?","name":"articletitle","label":"Article Title"},{"value":"HPB","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hpb.2019.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 International Hepato-Pancreato-Biliary Association Inc. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}